Price Increases and New Drugs Drive Increased Expenditures for Multiple Sclerosis

por Schafer, Jeremy A., Gunderson, Brent W., Gleason, Patrick P.
Publicado 2010

Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications

por Gleason, Patrick, Starner, Catherine I., Gunderson, Brent W., Schafer, Jeremy A., Sarran, H. Scott
Publicado 2009

Utilization, Cost Trends, and Member Cost - Share for Self-Injectable Multiple Sclerosis Drugs-Pharmacy and Medical Benefit Spending From 2004 Through 2007

por Kunze, April M., Gunderson, Brent W., Gleason, Patrick P., Heaton, Alan H., Johnson, Steven V.
Publicado 2007

Generic Drug Discount Programs: Are Prescriptions Being Submitted for Pharmacy Benefit Adjudication?

por Tungol, Alexandra, Starner, Catherine I., Gunderson, Brent W., Schafer, Jeremy A., Qiu, Yang, Gleason, Patrick P.
Publicado 2012

Health Plan Utilization and Costs of Specialty Drugs Within 4 Chronic Conditions

por Gleason, Patrick P., Alexander, G. Caleb, Starner, Catherine I., Ritter, Stephen T., Van Houten, Holly K., Gunderson, Brent W., Shah, Nilay D.
Publicado 2013